Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization
- PMID: 10224224
- DOI: 10.1096/fasebj.13.8.805
Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization
Abstract
Nonenzymatic cytosolic fatty acid binding proteins (FABPs) are abundantly expressed in many animal tissues with high rates of fatty acid metabolism. No physiological role has been demonstrated for any FABP, although these proteins have been implicated in transport of free long-chain fatty acids (LCFAs) and protection against LCFA toxicity. We report here that mice lacking heart-type FABP (H-FABP) exhibit a severe defect of peripheral (nonhepatic, non-fat) LCFA utilization. In these mice, the heart is unable to efficiently take up plasma LCFAs, which are normally its main fuel, and switches to glucose usage. Altered plasma levels of LCFAs, glucose, lactate and beta-hydroxybutyrate are consistent with depressed peripheral LCFA utilization, intensified carbohydrate usage, and increased hepatic LCFA oxidation; these changes are most pronounced under conditions favoring LCFA oxidation. H-FABP deficiency is only incompletely compensated, however, causing acute exercise intolerance and, at old age, a localized cardiac hypertrophy. These data establish a requirement for H-FABP in cardiac intracellular lipid transport and fuel selection and a major role in metabolic homeostasis. This new animal model should be particularly useful for investigating the significance of peripheral LCFA utilization for heart function, insulin sensitivity, and blood pressure.
Similar articles
-
Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene.Circ Res. 1999 Aug 20;85(4):329-37. doi: 10.1161/01.res.85.4.329. Circ Res. 1999. PMID: 10455061
-
Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise.Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E292-7. doi: 10.1152/ajpendo.00287.2004. Epub 2004 Sep 28. Am J Physiol Endocrinol Metab. 2005. PMID: 15454399
-
Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice.FASEB J. 2004 Feb;18(2):347-9. doi: 10.1096/fj.03-0330fje. Epub 2003 Dec 4. FASEB J. 2004. PMID: 14656998
-
Skeletal muscle fatty acid transport and transporters.Adv Exp Med Biol. 1998;441:193-205. doi: 10.1007/978-1-4899-1928-1_18. Adv Exp Med Biol. 1998. PMID: 9781326 Review.
-
Fatty acid-binding proteins in the heart.Mol Cell Biochem. 1998 Mar;180(1-2):43-51. Mol Cell Biochem. 1998. PMID: 9546629 Review.
Cited by
-
Metabolic cardiomyopathies.Int J Exp Pathol. 2000 Dec;81(6):349-72. doi: 10.1046/j.1365-2613.2000.00186.x. Int J Exp Pathol. 2000. PMID: 11298185 Free PMC article. Review.
-
Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-Based Screening.Biochemistry. 2019 Oct 22;58(42):4304-4316. doi: 10.1021/acs.biochem.9b00625. Epub 2019 Oct 11. Biochemistry. 2019. PMID: 31539229 Free PMC article.
-
Heart-type fatty acid-binding protein is essential for efficient brown adipose tissue fatty acid oxidation and cold tolerance.J Biol Chem. 2011 Jan 7;286(1):380-90. doi: 10.1074/jbc.M110.184754. Epub 2010 Nov 1. J Biol Chem. 2011. PMID: 21044951 Free PMC article.
-
Cardiac Metabolism and Contractile Function in Mice with Reduced Trans-Endothelial Fatty Acid Transport.Metabolites. 2021 Dec 19;11(12):889. doi: 10.3390/metabo11120889. Metabolites. 2021. PMID: 34940647 Free PMC article. Review.
-
Genetic influences in sport and physical performance.Sports Med. 2011 Oct 1;41(10):845-59. doi: 10.2165/11593200-000000000-00000. Sports Med. 2011. PMID: 21923202 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases